See the DrugPatentWatch profile for Thalidomide
What are thalidomide drugs, and what are they used for?
Thalidomide drugs are medicines whose main active ingredient is thalidomide. They were first known for causing severe birth defects but are used today for specific diseases under strict controls.
In current medical use, thalidomide is used to treat:
- Multiple myeloma, typically in combination with other medicines in patients who meet specific criteria [1]
- Certain complications of leprosy (Hansen’s disease), such as erythema nodosum leprosum (ENL) [2]
Why is thalidomide restricted so heavily?
Thalidomide is restricted because it can cause life-threatening and severe birth defects if taken during pregnancy. This risk is the reason many countries require a tightly controlled pregnancy-prevention program for people who can become pregnant and for healthcare providers [1][2].
How are thalidomide medicines taken, and how does dosing usually work?
Thalidomide is taken by mouth (oral dosing). The exact dose and schedule depend on the condition being treated and the patient’s situation, including other medications used alongside it (for example, in multiple myeloma regimens) [1].
What side effects do patients ask about most?
Common concerns with thalidomide include side effects related to nerve function, blood clots, and sedation. Because it is used in combination regimens for some cancers, side effects can also come from the partner drugs. Patients are typically monitored for complications such as neuropathy (nerve damage) and thromboembolic events (blood clots) [1][2].
What are the main interactions and safety checks?
Thalidomide can interact with other medicines and may increase risk of serious events in certain situations. Clinicians commonly review a patient’s full medication list and risk factors before prescribing and during treatment, especially for clotting risk and pregnancy-related safety requirements [1][2].
What conditions are treated with thalidomide compared with lenalidomide or pomalidomide?
Thalidomide is often compared with newer “thalidomide-like” drugs such as lenalidomide and pomalidomide, which may be used for overlapping indications like multiple myeloma, usually with different side-effect profiles and dosing approaches. All of these medicines share the same core concern about pregnancy risk due to their class-related teratogenicity, so restrictions are similar in principle [1].
Where can you find prescribing information or drug labeling?
If you need exact dosing, boxed warnings, contraindications, and monitoring guidance, the most reliable source is the official prescribing information for the specific thalidomide brand or product in your country.
---
Sources:
[1] https://www.ema.europa.eu/en/medicines/human/EPAR/thalidomide
[2] https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/thalidomide-embryofetal-toxicity-risk-pregnancy-and-birth-defects